Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease

Summary: Clinical trial participation across disease areas, including Alzheimer's disease (AD), has been biased towards White participants of European ancestry. To support clinical decision-making across diverse populations, we must recognize and address barriers to trial participation. To inform th...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Alexandria Wise-Brown, Sharon A. Brangman, J. Neil Henderson, Monica Willis-Parker, Stephanie Monroe, Jacobo E. Mintzer, Michael Grundman, Janice Smith, Rachelle S. Doody, Helen Lin, Beverly Assman, Gregory A. Rippon, Rozanno Gonzales, Sheila Seleri Assunção
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2024-07-01
Ráidu:	EClinicalMedicine
Fáttát:	Clinical trial protocol Diversity, Equity, Inclusion Underrepresentation Alzheimer's disease Social determinants of health
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2589537024002724
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!